Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05834816 · ClinicalTrials.gov registry record · NA
Stress and Neurofeedback in Anorexia Nervosa
A NA study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05834816: Clinical Trial NA study, sponsored by University of California, San Diego.
NCT05834816 is a NA study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05834816, a NA study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Anorexia nervosa (AN) and atypical AN (AAN) are severe psychiatric illnesses associated with high disease burden including high treatment costs and excessive mortality rates. Primary characteristics of AN and AAN are food restriction, associated fear of weight gain, and a disturbance in how one's body weight or shape is experienced.The underlying neural mechanisms for the core illness behaviors of food restriction and body size overestimation in anorexia nervosa and atypical anorexia nervosa are not well understood. This project will use neurofeedback and advanced psychophysical methods to assess and moderate the neural and behavioral responses to stress and relate those results to the naturalistic environment. The results will guide the development of novel interventions.
Primary Outcome
Activation in the brain during a taste reward task will be measured using functional MRI (fMRI) after a neutral and stressful task.
Interventions
- BEHAVIORAL Negative Affect Task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2025-03-25 |
| Phase | NA |
Why NCT05834816 stopped before completion
NCT05834816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Negative Affect Task is the first listed.
NCT05834816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05834816 about?
NCT05834816 is a clinical study titled "Stress and Neurofeedback in Anorexia Nervosa". Anorexia nervosa (AN) and atypical AN (AAN) are severe psychiatric illnesses associated with high disease burden including high treatment costs and excessive mortality rates. Primary characteristics of AN and AAN are food restriction, associated fear of weight gain, and a disturbance in how one's bo...
What is the current status of trial NCT05834816?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-04-26. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT05834816?
The interventions under investigation include: Negative Affect Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT05834816?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05834816's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI